A Phase 2 Trial of Belzupacap Sarotalocan (AU-011), an Investigational, Virus-Like Drug Conjugate (VDC) for the Treatment of Primary Indeterminate Lesions and Small Choroidal Melanoma (IL/CM) using Suprachoroidal Administration – (NCT04417530)
![](https://aurabiosciences.com/wp-content/themes/aura/img/hero-press.jpg)
Press Release